Outcomes of Patients on Maintenance Hemodialysis Admitted to a Tertiary Care Hospital with COVID-19 by Cheema, Mudassar Murtaza et al.
78                                              Journal of Rawalpindi Medical College (JRMC); 2021; 25 COVID-19 Supplement-1: 78-83 
Original Article 
 
Outcomes of Patients on Maintenance Haemodialysis 
Admitted to a Tertiary Care Hospital with COVID-19 
Mudassar Murtaza Cheema1, Zein El Amir2, Zeeshan Qadeer3, Ahmed Trimzi4 
1 Senior Registrar, Department of Nephrology, 
Benazir Bhutto Hospital, Rawalpindi.  
2 Head of Department, Department of Urology, 
Rawalpindi Medical University, Rawalpindi.  
3 Assistant Professor, Department of Urology, 
Rawalpindi Medical University, Rawalpindi. 
4 Registrar, Department of Nephrology, 
Benazir Bhutto Hospital, Rawalpindi.
Author`s Contribution 
1,2,3 Conception of study  
1,4 Experimentation/Study conduction  
1 Analysis/Interpretation/Discussion  
1,4 Manuscript Writing 
1 Critical Review 
4 Facilitation and Material analysis 
Corresponding Author 
Dr. Ahmed Tirmizi 
Registrar, 
Department of Nephrology, 




Received:  26/04/2021 
Accepted:  30/08/2021 
 
 
Cite this Article: Cheema, M.M., Amir, Z.E., Qadeer, 
Z., Trimzi, A. Outcomes of Patients on Maintenance 
Haemodialysis Admitted to a Tertiary Care Hospital 
with COVID-19. Journal of Rawalpindi Medical 
College. 31 Aug. 2021; 25 COVID-19 Supplement-1, 
78-83.  
DOI: https://doi.org/10.37939/jrmc.v25i1.1647 
    Conflict of Interest: Nil 







Introduction: The coronavirus disease-2019 pandemic has caused a disastrous world health crisis. The patients 
with renal disease, particularly those who are receiving regular dialysis therapy have an elevated risk of COVID-
19 infection-associated complications as well as poor prognosis including enhanced risk of hospital admission, 
mechanical ventilation, and mortality. 
Objective: The objective of the study is to assess the outcomes of patients on maintenance dialysis admitted to a 
tertiary care hospital with COVID-19. 
Materials and Methods: This retrospective study was performed in a Tertiary Care Hospital from March 2020 to 
August 2020. A total of 44 patients were included in the study. Data collected through a questionnaire was 
analyzed using the computer software SPSS 24.0. Frequencies and percentages were calculated for categorical 
data while mean+SD was calculated for quantitative data. 
Results: Among 44 patients, 63.6% were males and the mean age was 46.86+12.413 years. The mean number of 
dialysis during hospital stays was 3.57+2.214. The mean ferritin level was 2067.05+788.412 ng/ml and the mean 
C-reactive protein level was 111.59+32.998 mg/L. Among these patients, 65.9% were discharged and 34.1% of 
patients expired. 
Conclusion: The study concluded that elevated levels of inflammatory markers such as ferritin and CRP are 
found among patients on maintenance dialysis with COVID-19. 
Keywords: Outcomes, dialysis, COVID-19, patients, expired.  
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Introduction 
 
The recent COVID-19 (Coronavirus disease-2019) 
pandemic due to SARS-CoV-2 (Severe Acute 
Respiratory Syndrome-Corona Virus 2)1, initially 
emerged during December 2019 in Wuhan city of 
China2 and as per WHO (World Health Organization) 
it has spread to 2012 areas of world countries 
including Pakistan3; finally acquired the status as 
“Global Pandemic” on March 11, 2020, by WHO.4 
The COVID-19 has had detrimental effects worldwide5 
as above 38 million cases infected with the SARS-CoV-
2 were reported globally.6 In Pakistan, the Coronavirus 
pandemic outbreak occurred in February 2020.7 As per 
the Ministry of Health, Pakistan, there were 564,824 
confirmed COVID-19 cases. Among these cases, 
527,061 recovered, 1,648 were critical and 12,380 died 
till February 16, 2021. The highest number of COVID-
19 cases have been reported in the Province of Sindh 
(254,016) followed by Punjab (164,696), Khyber 
Pakhtunkhwa (69,885), Islamabad (42,808), Balochistan 
(18,946), Azad Jammu & Kashmir (9,532), and Gilgit 
Baltistan (4,941).8 
Almost after a 5 to 6 days incubation period, COVID-
19 symptoms start to appear.9 The disease clinical 
presentation is greatly variable, from symptom-
free/mild disease (<80 percent), to acute with 
unilateral/bilateral pneumonia (about 15 percent).10 
The routes of transmission comprise droplet 
inhalation, person-to-person direct transmission 
during sneezing, coughing, and with the contact of 
nasal, oral, as well as mucous membranes of the eye.11 
The disease identification is based upon real-time RT-
PCR (reverse transcriptase polymerase-chain-reaction) 
assay on the nasopharyngeal swabs. Most of the 
COVID-19 patients present with elevated to normal 
leukocyte counts, lymphopenia, elevated plasma pro-
inflammatory cytokines such as CRP (C-reactive 
protein), serum ferritin, procalcitonin, abnormal test 
results of liver and kidney function.9 The COVID-19 
patient's largest series reported co-morbidities for 
example, hypertension, obesity, diabetes, 
immunodeficiency, and cardiovascular diseases were 
associated with enhanced mortality.12  
Coronavirus disease-2019 is an important threat to 
patients undergoing maintenance dialysis.13 Severe 
infection of COVID-19 could cause AKI (acute kidney 
injury) that is linked with enhanced mortality.14 
However, the maintenance dialysis patients (MDPs) 
seem to be at higher risk of infectivity because of the 
viral transmission besides an increased risk of death 
when compared with the general populace, even 
despite mild medical presentation.14,15 Adaptive 
resistant systems and derangements in innate could be 
accountable for a decreased antiviral reaction,16 while 
innate resistant system chronic activation, as well as 
endothelial malfunction, offer a background regarding 
the more acute course. The presence of acute co-
morbidities for example, diabetes mellitus, 
cardiovascular disease, increased age, and 
hypertension could cause a rapid worsening of the 
patient's clinical situation in case of acute 
infectivity.14,17 
As the world continues to rage a war against the 
pandemic of COVID-19, the evidence about dismal 
diagnosis among patients on maintenance dialysis is 
worrisome. Though, apart from the infection itself, the 
significant challenges in underdeveloped and 
developing countries add insult to enhanced 
morbidity and mortality among this populace.18 No 
much data is available regarding the impact of 
COVID-19 on the clinical outcomes of patients 
on maintenance dialysis.19 So, the objective of the study 
is to assess the outcomes of patients on maintenance 
dialysis admitted to a tertiary care hospital with 
COVID-19. 
 
Materials and Methods 
 
This retrospective study was carried out in a Tertiary 
Care Hospital from March 2020 to August 2020. A 
total of 44 patients were included in the study.13 
During the study only hospitalized patients on twice-
weekly maintenance hemodialysis with COVID-19 
were included. The patients aged <18 years and those 
who were hospitalized due to other reasons were not 
included in the study. 
A COVID-19 case was defined by a positive result on 
RT-PCR assay based upon WHO standard and 
targeting the SARS-CoV-2 E gene and RdRp gene of a 
specimen collected on a nasopharyngeal swab.  
Dataset included age, gender, number of dialysis 
during the hospital stay, medications (heparin 
prophylaxis, dexamethasone), and inflammatory 
markers (ferritin, C-reactive protein). Patients’ need 
for oxygen dependency and mechanical ventilation 
were also noted. The main study outcome was defined 
as in-hospital mortality. 
Data collected through a questionnaire was analyzed 
using computer software SPSS 24.0. Frequencies and 
percentages were calculated for categorical data, while 
mean + SD was calculated for quantitative data. Chi-
square test was applied to find out the association 
between the outcome of patients with age, gender, 
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number of dialysis, medications, and mechanical 
ventilation. A P-value <0.05 was considered 
statistically significant. Confidentiality of the data was 





Table 1 describes that among 44 patients, 27 (61.4%) 
were up to 50 years old and 17 (38.6%) were more than 
50 years old while the mean age of the patients was 
46.86+12.413 years. 
Out of 44 patients, 28 (63.6%) were male and 16 
(36.4%) were females.  
Among these patients, the mean number of dialysis 
done during hospital stay was 3.57+2.214 while the 
range was 1-9.  
The result shows that among 44 patients, the majority 
35 (79.5%) was given heparin prophylaxis while only 9 
(20.5%) patients were not given heparin prophylaxis.  
Table highlights that among 44 patients, more than 
half 26 (59.1%) were given dexamethasone while 18 
(40.9%) patients were not given dexamethasone.  
Among 44 patients, the mean ferritin level was 
2067.05+788.412 ng/ml and the range was 800-4008 
ng/ml. Similarly among male patients, the mean 
ferritin level was 2109.61+729.125 ng/ml and the 
range was 864-3455 ng/ml while among female 
patients, the mean ferritin level was 1992.56+903.151 
ng/ml and the range was 800–4008 ng/ml. 
The result indicates that among patients the mean C-
reactive protein level was 111.59+32.998 while the 
range was 68-210.  
Table 1 depicts that all (100.0%) patients were oxygen-
dependent.  
Out of 44 patients, only 10 (22.7%) were on a 
mechanical ventilator while the majority 34 (77.3%) 
did not require mechanical ventilation.  
When the outcomes were evaluated, the result 
demonstrates that 29 (65.9%) patients were discharged 
from the hospital and 15 (34.1%) patients expired.  
Table 2 depicts that among 27 patients who were up to 
50 years old, 21 (47.7%) were discharged and 6 (13.7%) 
expired. Among 17 patients who were above 50 years 
old, 8 (18.2%) were discharged and 9 (20.4%) expired. 
The result was found statistically insignificant 
(P=0.444). 
Among 28 patients who were males, 19 (43.2%) were 
discharged and 9 (20.4%) expired. Among 16 patients 
who were females, 10 (22.7%) were discharged and 6 
(13.7%) expired. The result was found statistically 
insignificant (P=0.718). 
Among 33 patients who had up to 5 dialyses, 21 
(47.7%) were discharged and 12 (27.3%) expired. 
Among 11 patients who had more than 5 dialyses, 8 
(18.2%) were discharged and 3 (6.8%) expired. The 
result was found statistically insignificant (P=0.630). 
Among 35 patients who were given heparin 
prophylaxis, 23 (52.2%) were discharged and 12 
(27.3%) expired. Among 9 patients who were not given 
heparin prophylaxis, 6 (13.6%) were discharged and 3 
(6.8%) expired. The result was found statistically 
insignificant (P=0.957). 
Among 26 patients who were given dexamethasone, 
16 (36.4%) were discharged and 10 (22.7%) expired. 
Among 18 patients who were not given 
dexamethasone, 13 (29.5%) were discharged and 5 
(11.4%) expired. The result was found statistically 
insignificant (P=0.462). 
Among 10 patients who were on mechanical 
ventilation, all (22.7%) were expired. Among 34 
patients who were not on mechanical ventilation, 29 
(65.9%) were discharged and 5 (11.4%) expired. The 
result was found statistically significant (P=0.000). 
 
Table 1: Demographic features and outcomes of 
maintenance dialysis patients with COVID-19 
Demographic features  
Age n (%) 
<50 years 27 (61.4%) 
>50 years 17 (38.6%) 
mean+SD [min – max] 46.86+12.413 
[23 – 74] 
Gender  n (%) 
Male 28 (63.6%) 
Female  16 (36.4%) 
Dialysis, mean+SD [min – max] 3.57+2.214 
[1 – 9] 
Heparin prophylaxis  n (%) 
Yes 35 (79.5%) 
No  9 (20.5%) 
Dexamethasone  n (%) 
Yes 26 (59.1%) 
No  18 (40.9%) 
Ferritin (ng/ml), mean+SD  
[min – max] 
2067.05+788.412 
[800 – 4008] 
Male 2109.61+729.125 
[864 – 3455] 
Female  1992.56+903.151 
[800 – 4008] 
C-reactive protein (mg/L), 
mean+SD [min – max] 
111.59+32.998 
[68 – 210] 
Oxygen dependency, n (%) 44 (100.0%) 
Mechanical ventilation n (%) 
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Yes 10 (22.7%) 
No  34 (77.3%) 
Outcome n (%) 
Discharged  29 (65.9%) 
Expired  15 (34.1%) 
 
 
Figure-1: Age of patients  
 
 
Figure-2: Gender of patients  
 
 






Table-2: Factors associated with outcomes of 
maintenance dialysis patients with COVID-19 
 Outcome  p-
value Discharged Expired 
Age, n (%) 
   <50 years 21 (47.7%) 6 (13.7%) 0.444 
   >50 years 8 (18.2%) 9 (20.4%)  
    
Gender, n 
(%) 
   
   Male 19 (43.2%) 9 (20.4%) 0.718 
   Female  10 (22.7%) 6 (13.7%)  
    
Dialysis, n 
(%) 
   
   <5 21 (47.7%) 12 (27.3%) 0.630 
   >5 8 (18.2%) 3 (6.8%)  
    
Heparin prophylaxis, n (%) 
   Yes 23 (52.3%) 12 (27.3%) 0.957 
   No 6 (13.6%) 3 (6.8%)  
    
Dexamethasone, n (%) 
   Yes 16 (36.4%) 10 (22.7%) 0.462 
   No 13 (29.5%) 5 (11.4%)  
    
Mechanical ventilation, n (%) 
   Yes 0 (0.0%) 10 (22.7%) 0.000 




The Coronavirus disease 2019 is an emerging public 
health problem that represents a significant threat to 
maintenance dialysis patients. The current study was 
carried out to assess the outcomes of patients on 
maintenance dialysis admitted to a Tertiary Care 
Hospital of Rawalpindi with COVID-19. To acquire 
appropriate outcomes, a group of 44 patients was 
included in the study and found that most of the 
patients (61.4%) were up to 50 years old and 38.6% 
were above 50 years old (age range 23-74 years) while 
the mean age of the patients was 46.86+12.413 years. 
But the findings of a study performed by Javaid and 
coworkers (2020) showed that the mean age of the 
patients on maintenance dialysis was 59.92 years.2 In 
another study carried out by Ahmed and associates 
(2020) reported that the mean age of the patients was 
52+12 years while the age range was 20 to 85 years.10 A 
similar study conducted by Jung and collaborators 
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(2020) confirmed that the mean age of the patients was 
63.5+14.5 years and the range was 40–88 years.16   
When the gender of patients was assessed, the study 
disclosed that the majority (63.6%) of the patients were 
male while 36.4% were female patients. The findings 
of our study are comparable with a study undertaken 
by  Trivedi and partners (2020) who demonstrated that 
male patients were in majority (64.8%).18 A study was 
done by Turgutalp and coworkers (2020) also 
confirmed that among patients, more than half (52.2%) 
were males and 47.8% were female patients.19 The 
findings of our study further revealed that the mean 
number of inpatient dialysis was 3.57+2.214 (range 1-
9) and most of the patients were given heparin 
prophylaxis and dexamethasone.  
Ferritin is an inflammatory marker; its elevated level 
could be detrimental for the survival of patients on 
maintenance dialysis and are linked with elevated 
mortality risk. It was very discouraging that elevated 
ferritin levels were found among both male and female 
patients on maintenance dialysis with COVID-19. The 
mean ferritin level of patients was 2067.05+788.412 
ng/ml and the range was 800-4008 ng/ml. The 
findings of a most recent study carried out by Chan 
and fellows (2021) exhibited a better scenario than our 
study results who confirmed that the mean ferritin 
level of patients was 1041 ng/ml while the range was 
464-2556 ng/ml.5 The results of another study 
conducted by Islam and comrades (2021) are much 
better than our study results who reported that the 
mean ferritin level of patients was 950±548.11    
Likewise, it is also observed that elevated levels of 
CRP are associated with mortality risk among patients 
on maintenance dialysis. During the study elevated level of 
this inflammatory marker (CRP) was also found among 
patients on maintenance dialysis with COVID-19. The 
mean CRP level of patients was 111.59+32.998 mg/L 
while the range was 68-210 mg/L. The findings of our 
study are comparable but demonstrated a more 
devastating situation than the study done by 
Tortonese and colleagues (2020) who asserted that the 
mean CRP level of patients was 65 mg/L while the range 
was 6-123 mg/L.13 Another study performed by Stefan 
et al. (2021) highlighted that among patients mean 
CRP was 96 mg/L while the range was 23-192 mg/L. 
But Chan and fellows (2021) reported more CRP 
values than our study and confirmed that the mean 
CRP of patients was 153 mg/L and the range was 80-
250 mg/L.5  
It is pertinent to mention that in our study only 22.7% 
of patients required mechanical ventilation while a 
study carried out by Turgutalp and coworkers (2020) 
elucidated that a significant majority (69.5%) of the 
patients required mechanical ventilation.  
The mortality rate is observed high among patients on 
maintenance dialysis with COVID-19. In our study 15 
patients expired in the hospital (mortality rate 34.1%). The 
findings of our study are almost comparable with a study 
conducted by Javaid and coworkers (2020) who asserted 
that the in-hospital mortality rate was 35.7%.2 Several 
studies carried out in different parts of the world by 
Islam et al. (2021)11, Trivedi et al. (2020)18 Tortonese et 
al. (2020),13 Jung et al. (2020),16, and Luo et al., (2020)20 
reported that mortality rates were 17.6%, 37.8%, 27.3%, 
14.3%, and 18.5%, respectively.   
During the study association of outcome 
(discharged/expired) with patients’ age, gender, 
dialysis, heparin prophylaxis, dexamethasone, and 
mechanical ventilation was evaluated. A study 
showed significant association (P<0.05) only with 
mechanical ventilation while other variables had an 
insignificant association (P>0.05). A study carried out 
by Stefan and coworkers (2021) found a significant 
association (P=0.04) between outcome and age but an 
insignificant association (P=0.06) between outcome 
and gender.6 Chan and fellows (2021) showed 
insignificant association (P=0.96) between outcome 
and heparin. Another study conducted by Turgutalp 
and coworkers (2020) demonstrated a significant 
association (P<0.001) between outcome and 




The study concluded that elevated levels of 
inflammatory markers such as ferritin and CRP are 
found among patients on maintenance dialysis with 
COVID-19 and have no significant association with 
outcomes. Further large-scale studies are required to 
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